The round, which brought total funding to date to $7.6m, saw the participation from ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners.
The company intends to use the funds to accelerate research partnerships, onboard new partners such as Genetic Alliance, and expand platform development and marketing teams.
Led by Bob Kain, CEO and co-founder, LunaPBC is a health and genomic data platform owned by its community of personal health information donors. LunaDNA allows individuals to share their health data for medical research. The platform will reward individuals for sharing health data and promises utility to pharmaceutical, insurance, and healthcare IT companies, as they improve health outcomes through the discovery of new therapies and a deeper understanding of patient outcomes.
In December 2018, LunaDNA received precedent-setting qualification from the U.S. Securities and Exchange Commission (SEC) to recognize an individual’s genomic and health data as currency with which to acquire shares of ownership in the company. This offering ensures members share in the value created from research performed on the platform. Members have the opportunity to advance research, receive shares in the company commensurate with their contribution activity, and engage with utility apps and partners that align with their interests.
LunaDNA currently accepts DNA files from vendors including 23andMe, AncestryDNA, MyHeritage, and FamilyTree DNA, as well as LunaDNA-generated health surveys. The acceptance of new information types will be accelerated as a result of funding and include whole genome and exome DNA files, RNA, microbiome, electronic health records (EHRs), fitness and activity trackers, smart devices, and more.
FinSMEs
09/05/2019